Revolutionizing Cancer Treatment: Oncology Expertise

Breast cancer is a complex and multifaceted disease that affects millions of people worldwide. We are proficient in a variety of in vitro and in vivo breast cancer assays, capable of evaluating the efficacy, safety, and pharmacokinetic properties of potential anti-cancer compounds, cellular therapies, and gene-editing technologies. We offer a comprehensive suite of breast cancer research services tailored to address the diverse challenges posed by this disease.

Myeloma is a type of blood cancer that develops from plasma cells. Antibodies are proteins that help the immune system fight infection. In myeloma, the plasma cells become cancerous and grow uncontrollably in the bone marrow, the spongy tissue inside bones where blood cells are made. Myeloma is a relatively rare cancer, accounting for about 1% of all cancers in the United States. We recognize that each myeloma drug candidate has unique characteristics and requirements. That’s why we take a personalized approach to preclinical research, carefully tailoring our studies to evaluate the specific challenges and opportunities of your therapeutic compound.

Colorectal cancer is a cancer of the colon or rectum. It is the third most common cancer in the United States, and the second leading cause of cancer death in both men and women.  At Southern Research, we understand the critical role that fundamental research plays in guiding preclinical and clinical studies towards the successful development of novel colorectal cancer therapies. Our team of experienced scientists is dedicated to providing comprehensive and high-quality research and testing services that help our clients advance their drug candidates to the clinic with confidence.

Pancreatic cancer is a type of cancer that begins in the pancreas, a gland located behind the stomach in the abdomen. The pancreas plays a vital role in digestion by producing enzymes that break down food and hormones that regulate blood sugar levels. Pancreatic cancer is one of the most challenging and deadly cancers, with a five-year survival rate of around 9%. At Southern Research, we understand the urgency of finding effective treatments for pancreatic cancer, one of the most challenging and devastating malignancies. Our team of experienced scientists is dedicated to providing comprehensive and high-quality research and testing services that help our clients advance their drug candidates to the clinic with confidence.

Brain cancer is a broad term that encompasses a variety of tumors that arise from the brain or its lining membranes. These tumors can be classified according to their cell type, location, and behavior. Glioblastoma is the most common and aggressive type of primary brain cancer, accounting for about 45-55% of all primary brain tumors. It is characterized by rapid growth, invasiveness into surrounding brain tissue, and a dismal prognosis. We understand the unique challenges and complexities of brain cancer and glioblastoma research and testing. Our team of experienced scientists is dedicated to providing comprehensive and high-quality research and testing services that help our clients advance their drug candidates to the clinic with confidence.